Treatment of insomnia in elderly patients with headaches

The article describes  clinical cases of elderly patients with primary headaches and insomnia  managed in neurological practice. The first clinical case provides  details  of the  typical medical  history of a female  patient  with acute  insomnia  and episodic tension-type headache, the  second  one describes  the  typical medical  history of a patient  with chronic insomnia  and chronic migraine. Clinical examples  demonstrate common errors in the management of patients with insomnia  and primary headaches in real-life medical practice. The influence  of psychosocial  (stress, anxiety, negative  misconceptions about the disease,  dysfunctional   behaviour,  symptom  catastrophizing)  and  iatrogenic   (ordering  excessive   additional diagnostic   tests, over-diagnosing of detected structural changes  in the spine, neck vessels, brain, diagnostic  errors, prescribing  of ineffective treatment) factors on the development of insomnia and increase  of headaches in frequency is shown. The features  of the presented  clinical cases  are to demonstrate the relationship between insomnia  and increased frequency of primary headaches. Patients were  treated using  the  interdisciplinary program  comprising  non-drug  treatments and  drug  therapy. It has  been shown that the treatment of insomnia can not only improve the quality of sleep, but also reduce the frequency of headaches.

SonNorm Duo containing melatonin, motherwort extract  and peppermint leaf oil was used as a drug therapy  for acute  and chronic insomnia. Melatonin  and substances of plant  origin have a high level of effectiveness in the treatment of insomnia and are recommended as drugs to be used first to treat  insomnia. The drug therapy of acute  and chronic insomnia  was combined  with highly effective  non-drug  treatments: an educational program  to improve sleep  hygiene, cognitive  behavioural therapy, and relaxation exercises. During treatment, patients reported an improvement in their sleep quality as early as in the first month. A stable  normalization of sleep  and a significant decrease in headache frequency in a patient  with acute  insomnia and episodic  tension-type headache occurred  after  the  fifth week of treatment and in a patient  with chronic insomnia and chronic migraine after the second month of treatment. A 12-month follow-up of patients showed that the positive effect of the treatment was maintained.

1. Sateia MJ. International classification of sleep disorders – thirdedition: highlights and modifications. Chest. 2014;146(5):1387–1394. https://doi.org/10.1378/chest.14-0970.

2. Dopheide JA. Insomnia overview: epidemiology, pathophysiology, diagnosis and monitoring, and nonpharmacologic therapy. Am J Manag Care. 2020;26(Suppl. 4):S76–S84. https://doi.org/10.37765/ajmc.2020.42769.

3. Patel D, Steinberg J, Patel P. Insomnia in the Elderly: A Review. J Clin Sleep Med. 2018;14(6):1017–1024. https://doi.org/10.5664/jcsm.7172.

4. Morin CM, Jarrin DC. Epidemiology of Insomnia: Prevalence, Course, Risk Factors, and Public Health Burden. Sleep Med Clin. 2022;17(2):173–191. https://doi.org/10.1016/j.jsmc.2022.03.003.

5. De Bergeyck R, Geoffroy PA. Insomnia in neurological disorders: Prevalence, mechanisms, impact and treatment approaches. Rev Neurol (Paris). 2023;179(7):767–781. https://doi.org/10.1016/j.neurol.2023.08.008.

6. Lamkova IA, Parfenov VA. Insomnia in chronic non-specific low back pain. Neurology, Neuropsychiatry, Psychosomatics. 2021;13(5):62–67. (In Russ.) https://doi.org/10.14412/2074-2711-2021-5-62-67.

7. Poluektov MG, Golovatyuk AO. Sleep disorders in acute and chronic pain. Neurology, Neuropsychiatry, Psychosomatics. 2021;13(3):125–130. (In Russ.) https://doi.org/10.14412/2074-2711-2021-3-125-130.

8. Efremov IS, Asadullin AR, Dobrodeeva VS, Shnayder NA, Akhmetova EA, Tukhvatullina DR et al. Association of Polymorphic Variants of Genes (HTR2A, MTNR1A, MTNR1B, CLOCK, DRD2) and Insomnia in Alcohol Dependence Syndrome. Neurology, Neuropsychiatry, Psychosomatics. 2021;13(5):34–39. https://doi.org/10.14412/2074-2711-2021-5-34-39.

9. Cho SJ, Song TJ, Chu MK. Sleep and Tension-Type Headache. Curr Neurol Neurosci Rep. 2019;19(7):44. https://doi.org/10.1007/s11910-019-0953-8.

10. Tiseo C, Vacca A, Felbush A, Filimonova T, Gai A, Glazyrina T et al. Migraine and sleep disorders: a systematic review. J Headache Pain. 2020;21(1):126. https://doi.org/10.1186/s10194-020-01192-5.

11. Vgontzas A, Pavlović JM. Sleep Disorders and Migraine: Review of Literature and Potential Pathophysiology Mechanisms. Headache. 2018;58(7):1030–1039. https://doi.org/10.1111/head.13358.

12. Fang H, Tu S, Sheng J, Shao A. Depression in sleep disturbance: A review on a bidirectional relationship, mechanisms and treatment. J Cell Mol Med. 2019;23(4):2324–2332. https://doi.org/10.1111/jcmm.14170.

13. Chellappa SL, Aeschbach D. Sleep and anxiety: From mechanisms to interventions. Sleep Med Rev. 2022;61:101583. https://doi.org/10.1016/j.smrv.2021.101583.

14. Golovacheva VA, Parfenov VA, Tabeeva GR, Osipova VV, Smulevich AB, Andryushchenko AV, Golovacheva AA. The optimization of management of chronic daily headache patients. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2017;117(2):4–9. (In Russ.) https://doi.org/10.17116/jnevro2017117214-9.

15. Golovacheva VA, Golovacheva AA, Parfenov VA. Chronic migraine treatment: multidisciplinary approach. Case report. Terapevticheskii Arkhiv. 2021;93(12): 1528–1532. (In Russ.) https://doi.org/10.26442/00403660.2021.12.201247.

16. Golovacheva VA. Treatment of chronic migraine and insomnia with cognitive behavioral therapy. Meditsinskiy Sovet. 2023;17(3):68–76. (In Russ.) https://doi.org/10.21518/ms2023-080.

17. Markota M, Rummans TA, Bostwick JM, Lapid MI. Benzodiazepine Use in Older Adults: Dangers, Management, and Alternative Therapies. Mayo Clin Proc. 2016;91(11):1632–1639. https://doi.org/10.1016/j.mayocp.2016.07.024.

18. Brewster GS, Riegel B, Gehrman PR. Insomnia in the Older Adult. Sleep Med Clin. 2018;13(1):13–19. https://doi.org/10.1016/j.jsmc.2017.09.002.

19. Poluektov MG, Buzunov RV, Averbukh VM, Verbitsky EV, Zakharov AV, Kelmanson IA et al. Project of clinical recommendations on diagnosis and treatment of chronic insomnia in adults. Consilium Medicum. Neurology and Rheumatology (Suppl.). 2016;(2):41–51. (In Russ.) Available at: https://omnidoctor.ru/library/izdaniya-dlya-vrachey/consilium-medicum/cm2016/nevro2016_pril/nevro2016_2_pril/proekt-klinicheskikh-rekomendatsiy-po-diagnostike-i-lecheniyu-khronicheskoy-insomnii-u-vzroslykh/.

20. Riemann D, Baglioni C, Bassetti C, Bjorvatn B, Dolenc Groselj L, Ellis JG et al. European guideline for the diagnosis and treatment of insomnia. J Sleep Res. 2017;26(6):675–700. https://doi.org/10.1111/jsr.12594.

21. Smitherman TA, Kuka AJ, Calhoun AH, Walters ABP, Davis-Martin RE, Ambrose CE et al. Cognitive-Behavioral Therapy for Insomnia to Reduce Chronic Migraine: A Sequential Bayesian Analysis. Headache. 2018;58(7):1052–1059. https://doi.org/10.1111/head.13313.

22. Smitherman TA, Walters AB, Davis RE, Ambrose CE, Roland M, Houle TT, Rains JC. Randomized Controlled Pilot Trial of Behavioral Insomnia Treatment for Chronic Migraine With Comorbid Insomnia. Headache. 2016;56(2):276–291. https://doi.org/10.1111/head.12760.

23. Crawford MR, Luik AI, Espie CA, Taylor HL, Burgess HJ, Jones AL, Ong JC. Digital Cognitive Behavioral Therapy for Insomnia in Women With Chronic Migraines. Headache. 2020;60(5):902–915. https://doi.org/10.1111/head.13777.

24. Walker D, Zhang N, Natbony LR. Insomnia and Migraine: A Review of Evidence-Based, Biobehavioral Interventions. Curr Pain Headache Rep. 2023;27(2):19–25. https://doi.org/10.1007/s11916-023-01100-x.

25. Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd ed. Cephalalgia. 2018;38(1):1–211. https://doi.org/10.1177/0333102417738202.

26. Bendtsen L, Evers S, Linde M, Mitsikostas DD, Sandrini G, Schoenen J. EFNS guideline on the treatment of tension-type headache – report of an EFNS task force. Eur J Neurol. 2010;17(11):1318–1325. https://doi.org/10.1111/j.1468-1331.2010.03070.x.

27. Tabeeva GR, Osipova VV, Filatova EG, Azimova YuE, Amelin AV, Artyomenko AR et al. Evaluation and treatment of medication-overuse headache: Russian experts’ guidelines. Neurology, Neuropsychiatry, Psychosomatics. 2022;14(1):4–13. (In Russ.) https://doi.org/10.14412/2074-2711-2022-1-4-13.

28. Bashir A, Lipton RB, Ashina S, Ashina M. Migraine and structural changes in the brain: a systematic review and meta-analysis. Neurology. 2013;81(14):1260–1268. https://doi.org/10.1212/WNL.0b013e3182a6cb32.

29. Filatova EG, Osipova VV, Tabeeva GR, Parfenov VA, Ekusheva EV, Azimova YuE et al. Diagnosis and treatment of migraine: Russian experts’ recommendations. Neurology, Neuropsychiatry, Psychosomatics. 2020;12(4):4–14. (In Russ.) https://doi.org/10.14412/2074-2711-2020-4-4-14.

30. Osipova V, Ayzenberg I, Amelin A, Tarasova S, Sergeev A, Tabeeva G. PO556 The highest prevalence of CDH in Russia: why? Cephalalgia. 2015;35(Suppl. 6):287–288. https://doi.org/10.1177/0333102415581304.

31. Osipova VV, Azimova YuE, Tabeeva GR, Tarasova SA, Amelin AV, Kutsemelov IV et al. Diagnostics of headache in Russia and post-Soviet countries: state of the problem and ways for its solution. Annals of Clinical and Experimental Neurology. 2017;6(2):16–22. (In Russ.) Available at: https://annaly-nevrologii.com/journal/pathID/article/view/275/.

32. Golovacheva VA, Golovacheva AA, Fateeva TG, Volodarskaya EA. Illness perception in patients with chronic migraine: cognitive, emotional and behavioral aspects. Neurology, Neuropsychiatry, Psychosomatics. 2023;15(1):28–35. (In Russ.) https://doi.org/10.14412/2074-2711-2023-1-28-35.

33. Golovacheva VA, Golovacheva AA, Parfenov VA, Tabeeva GR, Romanov DV, Osipova VV, Katsarava Z. Cognitive behavioral therapy in the treatment of chronic migraine: a clinical case report. Neurology, Neuropsychiatry, Psychosomatics. 2021;13(1):74–80. (In Russ.) https://doi.org/10.14412/2074-2711-2021-1-74-80.

34. Kovrov GV, Posokhov SI, Shavlovskaia OA. The efficacy of Phenazepam in the treatment of insomnia in outpatient practice. Consilium Medicum. 2017;19(9):31–36. (In Russ.) Available at: https://consilium.orscience.ru/2075-1753/article/view/94859/.

35. Kotova OV, Akarachkova ES, Belyaev AA, Borodulina IV, Pavlova SV. Efficacy and safety of the combined drug SonNorm Duo in patients with insomnia: results of an open randomized comparative clinical trial. Effective Pharmacotherapy. 2022;18(36):78–83. (In Russ.) Available at: https://umedp.ru/upload/iblock/2b2/Kotova.pdf.

36. Parfenova EV. Insomnia and cognitive behavioral therapy for chronic back pain. Neurology, Neuropsychiatry, Psychosomatics. 2020;12(4):119–124. (In Russ.) https://doi.org/10.14412/2074-2711-2020-4-119-124.

37. Van Straten A, van der Zweerde T, Kleiboer A, Cuijpers P, Morin CM, Lancee J. Cognitive and behavioral therapies in the treatment of insomnia: A meta-analysis. Sleep Med Rev. 2018;38:3–16. https://doi.org/10.1016/j.smrv.2017.02.001.